CHICAGO -- Upfront laser trabeculoplasty significantly slowed glaucoma progression and vision loss as compared with eye drops, long-term follow-up from a large randomized trial showed. After 6 years ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Average IOP reductions were 23.04% at 6 months and 25.74 ...

Eyes that switched from eye drops to SLT had a significant reduction in the average number of medications. Eyes with uncontrolled IOP benefited from SLT, but some still needed trabeculectomy.

Alcon has announced the US release of its Voyager direct selective laser trabeculoplasty (DSLT) platform, with a launch event scheduled for the American Glaucoma Society annual meeting later in ...